Aβ-peptide length and apolipoprotein E genotype in Alzheimer's disease

Annals of Neurology

Volumn 39, Issue 3, 1996, Pages 395-399

  Gearing, Marla ^a   Mori, Hiroshi ^b   Mirra, Suzanne S ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; AMYLOID BETA PROTEIN; CARBOXYPEPTIDASE;

ALLELE; ALZHEIMER DISEASE; AMYLOID NEUROPATHY; ARTICLE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PRIORITY JOURNAL; RISK FACTOR; BRAIN CORTEX; ENZYMOLOGY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOPHYSIOLOGY; ULTRASTRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; CARBOXYPEPTIDASES; CEREBRAL CORTEX; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 0029664434     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410390320     Document Type: Article

References (30)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981
2. Strittmattet WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125:163-171
3. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580
4. Schmechel DE, Saunders AM, Strhtmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-9653
5. Wisniewski T, Castaño EM, Golabek A, et al. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 1994;145:1030-1035
6. Jarrett JT, Berger EP, Lansbury PT Jr. The C-terminus of the β protein is critical in amyloidogenesis. Ann NY Acad Sci 1993;695:144-148
7. Gearing M, Schneider JA, Rebeck GW, et al. Alzheimer's disease with and without coexisting Parkinson's disease changes: apohpoprotein E genotype and neuropathologic correlates. Neurology 1995;45:1985-1990
8. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486
9. Gearing M, Schneider JA, Robbins RS, et al. Regional variation in the distribution of apolipoprotein E and Aβ in Alzheimer's disease. J Neuropathol Exp Neurol 1995;54:833-841
10. Iwatsubo T, Odaka A, Suzuki N, et al. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonais: evidence that an initially deposited species is Aβ42(43). Neuron 1994;13:45-53
11. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923
12. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699
13. Kim KS, Miller DL, Sapienza VJ, et al. Production and characterization of monoclonal antibodies reactive to synthetic cere-brovascular amyloid peptide. Neurosci Res Commun 1988;2: 121-130
14. Greenberg SM, Rebeck GW, Vonstattle JPG, et al. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:254-259
15. Iwatsubo T, Mann DMA, Odaka A, et al. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann Neurol 1995;37:294-299
16. 1-42/43) of amyloid β protein as a seed molecule in cerebral deposits of Alzheimer's disease. Biochem Biophys Res Commun 1994;205:834-842
17. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 1995;38:634-648
18. Gearing M, Schneider JA, Green RC, Mirra SS. Striatal plaques occur relatively early in the progression of Alzheimer's disease changes. J Neuropathol Exp Neurol 1995;54:427 (Abstract)
19. Jarrett JT, Lansbury PT Jr. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993:73:1055-1058
20. Maggio JE, Stimson ER, Ghilard JR, et al. Reversible in vitro growth of Alzheimer disease β-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 1992;89: 5462-5466
21. 1-antichymotrypsin and apolipoprotein E promore assembly of Alzheimer β-protein into filaments. Nature 1994;372:92-94
22. Sanan DA, Weisgraber KH, Russell SJ, et al. Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform ApoE4 associates more efficiently than ApoE3. J Clin Invest 1994;94:860-869
23. LaDu MJ, Pederson TM, Frail DE, et al. Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J Biol Chem 1995,270:9039-9042
24. Barrow CJ, Zagorski MG. Solution structures of β pepride and its constituent fragments: relation to amyloid deposition. Science 1991;253:179-182
25. Younkin SG Evidence that Aβ42 is the real culprit in Alzheimer's disease. Ann Neurol 1995;37:287-288
26. Suzuki N, Cheung IT, Cai X-D, et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP) mutants. Science 1994;264:1336-1340
27. 1-40) in familial Alzheimer's disease brain. J Biol Chem 1994;269:32721-32724
28. Scheuner D, Bird T, Cirron M, et al. Fibroblasrs from carriers of familial AD linked to chromosome 14 show increased Aβ production. Soc Neurosci Abstr 1995;21:1500 (Abstract)
29. Song X-H, Suzuki N, Bird T, et al. Plasma amyloid β protein (Aβ) ending at Aβ42(43) is increased in carriers of familial AD (FAD) linked to chromosome 14. Soc Neurosci Abstr 1995;2: 1501 (Abstract)
30. Selkoe DJ. Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol 1994;53:438-447